{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:45:00Z","timestamp":1792687500357,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.oret.2025.03.024","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T19:39:29Z","timestamp":1743709169000},"page":"1005-1016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Guidelines for the Diagnosis, Management, and Study of Autoimmune Retinopathy from the American Academy of Ophthalmology's Task Force"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0717-0638","authenticated-orcid":false,"given":"Bobeck S.","family":"Modjtahedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6361-6767","authenticated-orcid":false,"given":"Alan G.","family":"Palestine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee M.","family":"Jampol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sarraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Nida","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Sobrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2294-0979","authenticated-orcid":false,"given":"Paul","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazyna","family":"Adamus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald S.","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3302-5754","authenticated-orcid":false,"given":"Cynthia X.","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3823-4826","authenticated-orcid":false,"given":"Flora","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2025.03.024_bib1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ajo.2013.09.019","article-title":"Autoimmune retinopathy","volume":"157","author":"Grange","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.024_bib2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/IAE.0000000000000119","article-title":"Autoimmune retinopathy and antiretinal antibodies: a review","volume":"34","author":"Grewal","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.03.024_bib3","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.survophthal.2012.09.001","article-title":"Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management","volume":"58","author":"Rahimy","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.024_bib4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archophthalmol.2009.24","article-title":"Management of autoimmune retinopathies with immunosuppression","volume":"127","author":"Ferreyra","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.024_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2415-4-5","article-title":"Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy","volume":"4","author":"Adamus","year":"2004","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.024_bib6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jcjo.2024.04.002","article-title":"Autoimmune retinopathy associated with systemic autoimmune disease: a case series","volume":"59","author":"Fouad","year":"2024","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.024_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0039-6257(02)00416-2","article-title":"Paraneoplastic retinopathies and optic neuropathies","volume":"48","author":"Chan","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.024_bib8","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ajo.2004.12.104","article-title":"Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies","volume":"139","author":"Weleber","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.024_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/13816810.2023.2245035","article-title":"Expanding the phenotypic and genotypic spectrum of patients with HGSNAT-related retinopathy","volume":"45","author":"da Palma","year":"2024","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.oret.2025.03.024_bib10","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.3390\/ijms23137398","article-title":"The clinical spectrum and disease course of DRAM2 retinopathy","volume":"23","author":"Krasovec","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.oret.2025.03.024_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.13.8.2","article-title":"Late-onset slowly progressing cone\/macular dystrophy in patients with the biallelic hypomorphic variant p.Arg1933Ter in RP1","volume":"13","author":"Choi","year":"2024","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.oret.2025.03.024_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000535430","article-title":"Phenotypic and genetic alterations in adult-onset cone and cone-rod dystrophy","volume":"67","author":"Kim","year":"2024","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.oret.2025.03.024_bib13","first-page":"T8","article-title":"Autoimmune retinopathy: current concepts and practices (an American Ophthalmological Society Thesis)","volume":"115","author":"Sen","year":"2017","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.oret.2025.03.024_bib14","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/IAE.0000000000004036","article-title":"Toward an imaging-centric definition of nonparaneoplastic autoimmune retinopathy","volume":"44","author":"Xu","year":"2024","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.03.024_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ajo.2016.05.013","article-title":"Consensus on the diagnosis and management of nonparaneoplastic autoimmune retinopathy using a modified delphi approach","volume":"168","author":"Fox","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.024_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/bjophthalmol-2012-302524","article-title":"SD-OCT and autofluorescence characteristics of autoimmune retinopathy","volume":"97","author":"Pepple","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.024_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00417-010-1436-4","article-title":"Slowly progressive non-neoplastic autoimmune-like retinopathy","volume":"249","author":"Ohta","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.024_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ophtha.2014.07.018","article-title":"Pericentral retinopathy and racial differences in hydroxychloroquine toxicity","volume":"122","author":"Melles","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.03.024_bib19","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.oret.2022.05.001","article-title":"Clinical and morphologic characteristics of perivenular fernlike leakage on ultrawide-field fluorescein angiography","volume":"6","author":"Ramtohul","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2025.03.024_bib20","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/ICB.0000000000001552","article-title":"Successful treatment of cancer-associated retinopathy with intravitreal dexamethasone implant followed by a 0.18-Mg fluocinolone implant without systemic immunosuppression","volume":"19","author":"Huang","year":"2025","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.oret.2025.03.024_bib21","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/IAE.0b013e3182398107","article-title":"Hyperautofluorescent ring in autoimmune retinopathy","volume":"32","author":"Lima","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.03.024_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/24741264241237023","article-title":"Circular perivascular autofluorescence pattern in patients with autoimmune retinopathy","volume":"8","author":"Yang","year":"2024","journal-title":"J Vitreoretin Dis"},{"key":"10.1016\/j.oret.2025.03.024_bib23","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/j.ophtha.2013.07.037","article-title":"Diagnosis of occult melanoma using transient receptor potential melastatin 1 (TRPM1) autoantibody testing: a novel approach","volume":"120","author":"Dalal","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.03.024_bib24","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1001\/archophthalmol.2009.311","article-title":"Melanoma-associated retinopathy: a paraneoplastic autoimmune complication","volume":"127","author":"Lu","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.024_bib25","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1038\/s41433-021-01604-z","article-title":"Negative electroretinograms: genetic and acquired causes, diagnostic approaches and physiological insights","volume":"35","author":"Jiang","year":"2021","journal-title":"Eye"},{"key":"10.1016\/j.oret.2025.03.024_bib26","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1523\/JNEUROSCI.6007-10.2011","article-title":"Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells","volume":"31","author":"Dhingra","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.oret.2025.03.024_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ajo.2020.05.024","article-title":"Baseline visual field findings in the RUSH2A study: associated factors and correlation with other measures of disease severity","volume":"219","author":"Duncan","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.024_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajo.2023.02.002","article-title":"Static perimetry in the rate of progression in USH2A-related retinal degeneration (RUSH2A) study: assessment through 2 years","volume":"250","author":"Duncan","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.024_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ajo.2022.07.005","article-title":"Plasma antiretinal autoantibody profiling and diagnostic efficacy in patients with autoimmune retinopathy","volume":"245","author":"Bae","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.024_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167909","article-title":"Serum autoantibody profiling of patients with paraneoplastic and non-paraneoplastic autoimmune retinopathy","volume":"11","author":"Ten Berge","year":"2016","journal-title":"PLOS One"},{"key":"10.1016\/j.oret.2025.03.024_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/17469899.2020.1739522","article-title":"Current techniques to accurately measure anti-retinal autoantibodies","volume":"15","author":"Adamus","year":"2020","journal-title":"Expert Rev Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.024_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/jamaophthalmol.2013.574","article-title":"Concordance of antiretinal antibody testing results between laboratories in autoimmune retinopathy","volume":"131","author":"Faez","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.024_bib33","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1001\/jamaophthalmol.2021.0651","article-title":"Clinical utility of antiretinal antibody testing","volume":"139","author":"Chen","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.024_bib34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.autrev.2009.01.002","article-title":"Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy","volume":"8","author":"Adamus","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.oret.2025.03.024_bib35","article-title":"Predictive value of genetic testing for inherited retinal diseases in patients with suspected atypical autoimmune retinopathy","volume":"15","author":"Stanwyck","year":"2019","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.oret.2025.03.024_bib36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archopht.117.4.471","article-title":"Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases","volume":"117","author":"Guy","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.024_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40942-017-0104-9","article-title":"Autoimmune retinopathy: a review","volume":"4","author":"Canamary","year":"2018","journal-title":"Int J Retin Vitr"},{"key":"10.1016\/j.oret.2025.03.024_bib38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ajo.2017.04.019","article-title":"Outcomes in autoimmune retinopathy patients treated with rituximab","volume":"180","author":"Davoudi","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.024_bib39","doi-asserted-by":"crossref","first-page":"515","DOI":"10.18502\/jovr.v17i4.12304","article-title":"Rituximab monotherapy versus rituximab and bortezomib combination therapy for treatment of non-paraneoplastic autoimmune retinopathy","volume":"17","author":"Maleki","year":"2022","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.oret.2025.03.024_bib40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0165-5728(02)00314-4","article-title":"Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway","volume":"132","author":"Shiraga","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.oret.2025.03.024_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100622","article-title":"Clinical outcomes of therapeutic interventions for autoimmune retinopathy: a meta-analysis and systematic review","volume":"5","author":"Kapoor","year":"2025","journal-title":"Ophthalmol Sci"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025001538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025001538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:29:53Z","timestamp":1759343393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653025001538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2468653025001538"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2025.03.024","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guidelines for the Diagnosis, Management, and Study of Autoimmune Retinopathy from the American Academy of Ophthalmology's Task Force","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2025.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}